top of page
Search

Why Should FMTVDM FRONTIER Come to Your Country?

  • Writer: Richard M Fleming, PhD, MD, JD
    Richard M Fleming, PhD, MD, JD
  • Dec 16, 2025
  • 2 min read

Updated: Dec 18, 2025

The question is not whether FMTVDM® works.  


  • Our science has been established.

  • Our patent has been secured.

  • Patients have already shown measurable benefit when treatment is guided by reproducible FMTVDM® results.


The question is deeper, sovereign, and historic:


Why should FMTVDM FRONTIER come to your country and embrace you as one of the first Select Nation Status (SNS) countries in the world?


The Science Is Proven


  • Complete body imaging: FMTVDM® now incorporates total body results, staging cancers at the same time the primary cancer is found.

  • Efficiency gains: Imaging time is reduced, and the amount of nuclear isotopes required is minimized.

  • Continuum of health and disease: The InflammoThrombotic Immunologic Response (ITIR) Disease (ITIRD) is measured reproducibly, mapping the body’s continuum from health to disease.


This is not speculation. It is reproducible science, already validated and patented.


The Covenant of Opportunity


Only three nations will be granted SNS designation until 2030. This is not a license alone — it is a sovereign mantle. If fewer than three nations are able to provide the results FMTVDM FRONTIER is looking for, we will stop and focus solely on those selected. There will not be a fourth SNS country before 2030.


  • Prestige: To be the first SNS country is to lead the world in reproducible medicine.

  • Equity: Your population gains earlier diagnosis, reproducible monitoring, and reduced exposure to isotopes.

  • Diplomacy: SNS status elevates your nation into a new league of global health leadership.

  • Legacy: You become custodian of reproducibility, ensuring science is safeguarded for generations.


The Fundamental Question


So we ask:

Who should be given this unique opportunity?  

Why should your country be chosen to lead the world in global health diagnostics and theranostics?


This is not merely about adopting a technology. It is about embracing a covenant — a treaty of science, sovereignty, and fellowship.


Closing Invocation


Nations do not grant legitimacy to FMTVDM.

FMTVDM FRONTIER is not seeking legitimacy — it is adding legitimacy to nations selected for Select Nation Status. By embracing SNS, a country does not validate FMTVDM; rather, FMTVDM elevates that nation into sovereign leadership of reproducible medicine.


FMTVDM FRONTIER stands ready.

The science is established.

The patent is secured.

The benefits are proven.


The question is not whether FMTVDM will lead the world. The question is which nations will be selected; to rise first, seal the covenant, and be remembered as pioneers in quantitative reproducible medicine.



"FMTVDM FRONTIER does not seek permission — it adds legitimacy. Prestige, Diplomacy, Equity, and Legacy await the nations chosen as SNS leaders."
"FMTVDM FRONTIER does not seek permission — it adds legitimacy. Prestige, Diplomacy, Equity, and Legacy await the nations chosen as SNS leaders."

 
 
 

Comments


IMG_1843_edited.png

EMAIL FMTVDM FRONTIER
CONSORTIUM
DIRECTLY

IMG_1927.gif
ai2.png

FMTVDM FRONTIER INQUIRY

Multi-line address
Drawing mode selected. Drawing requires a mouse or touchpad. For keyboard accessibility, select Type or Upload.

© 2025 by Richard M Fleming, PhD, MD, JD.

Director, FMTVDM FRONTIER Consortium

Powered and secured by Wix

bottom of page